Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND)

  1. Moreno-Pérez, D.
  2. Korobova, A.
  3. Croche-Santander, F.D.B.
  4. Cordón-Martínez, A.
  5. Díaz-Morales, O.
  6. Martínez-Campos, L.
  7. Pérez-González, E.
  8. Martínez-Padilla, M.D.C.
  9. Santos-Pérez, J.L.
  10. Brioso-Galiana, J.
  11. Sánchez-Códez, M.I.
  12. Del Diego-Salas, J.
  13. Rivera-Izquierdo, M.
  14. Lorusso, N.
Journal:
Vaccines

ISSN: 2076-393X

Year of publication: 2025

Volume: 13

Issue: 2

Type: Article

DOI: 10.3390/VACCINES13020175 GOOGLE SCHOLAR lock_openOpen access editor HANDLE: https://hdl.handle.net/10498/36317
RODIN. Repositorio Institucional UCA.: lock_openOpen access Handle
Data source: Scopus